The Paradigm Evolution of Biliary Stents: From Passive Drainage to Intelligent Diagnostic-Therapeutic Platforms.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 42727870.
- Also identified by DOI 10.1016/j.actbio.2026.09.021.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The clinical management of biliary obstruction has long relied on mechanical drainage provided by stents, yet the inherent risks of re-occlusion, infection, and migration underscore the fundamental limitations of this passive support paradigm. This review proposes a four-stage paradigm evolution framework for biliary stent technology, demonstrating a shift from "passive physical support" to an "active therapeutic platform." The first stage, represented by plastic and self-expandable metallic stents, established anatomical drainage but is limited by biofilm deposition, tumor ingrowth, and migration. The first paradigm shift introduced functionalized stents incorporating drug-eluting, radionuclide, or photothermal/photodynamic coatings, transforming stents into active therapeutic carriers. The second paradigm shift emphasizes bio-adaptation through fully biodegradable stents achieving "temporary support followed by disappearance," alongside cell/matrix coatings to promote tissue regeneration. A third paradigm shift is emerging, focusing on intelligent responsiveness and personalization through closed-loop systems integrating biosensors, wireless communication, and artificial intelligence for real-time monitoring and on-demand therapy, combined with 3D/4D printing for patient-specific adaptation. Through critical assessment of each stage, this review dissects translational challenges including evaluation standards, long-term safety, cost-effectiveness, and regulatory complexities. Ultimately, we present a clinical decision-oriented technological spectrum delineating stent positioning across benign and malignant biliary diseases, envisioning future dynamic platforms integrating diagnosis, treatment, and monitoring to advance biliary intervention into an era of data-driven precision therapy. STATEMENT OF SIGNIFICANCE: This review establishes, for the first time, a four-stage paradigm evolution framework for biliary stent technology-from passive mechanical support to active functionalized intervention, bio-adaptive scaffolds, and ultimately intelligent diagnostic-therapeutic platforms. By systematically dissecting the irreconcilable contradictions inherent to each paradigm, this framework provides a design-philosophy navigational map that transcends conventional chronological classifications. The integration of materials science mechanisms, cross-technology quantitative comparisons, and evidence-based clinical decision pathways offers both clinicians and biomaterials researchers a comprehensive reference for understanding the past trajectory and future direction of biliary stenting.